Submit a manuscript Sign up for article alerts Contact us

Journal App

google play app store

About Genome Medicine

This page includes information about the aims and scope of Genome Medicine, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

**Average time to first decision including peer review is just 28 days**

Genome Medicine publishes peer-reviewed research articles, new methods, software tools, reviews and comment articles in all areas of medicine studied from a post-genomic perspective. Areas covered include, but are not limited to, disease genomics (including genome-wide association studies and sequencing-based studies), disease epigenomics, pathogen and microbiome genomics, immunogenomics, translational genomics, pharmacogenomics and personalized medicine, proteomics and metabolomics in medicine, systems medicine, and ethical, legal and social issues.

**Data from May 2014.

Editorial team

Editor
Rebecca Furlong, PhD
Senior Editor
Maria Hodges, PhD
Acting Editor
Louisa Flintoft, PhD
Reviews Editor
Romina Andrew, PhD
Senior Assistant Editor
Andreia Cunha, PhD
Assistant Editor
Rabia Begum, PhD
Editorial Assistant
Elisabeth Kirton

Open access

All Research, Databases, Methods and Software articles published by Genome Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. In addition, the journal also publishes reviews and other article types that are only available by subscription.

Authors of Research, Databases, Methods and Software articles published in Genome Medicine are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Other content

In addition to research articles Genome Medicine also publishes Research highlights, Comments, Meeting reports, Opinions, Q and As and Reviews all of which are only available by subscription. BioMed Central holds the copyright to such subscription content according to the terms of BioMed Central's Copyright Licensing Agreement.

Article-processing charges

Open access publishing is not without costs. Genome Medicine therefore levies an article-processing charge of £1695/$2885/€2145 for each Research, Databases, Methods and Software article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in Genome Medicine are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Genome Medicine include:

  • CAS
  • Citebase
  • Google Scholar
  • Index Copernicus
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index
  • SCImago
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

Genome Medicine is tracked by Thomson Reuters (ISI) and has an Impact Factor of 3.91.

Publication and peer review process

Suitability of research for publication in Genome Medicine is dependent primarily on the scientific validity and coherence of the work, as well as broad interest, as assessed by reviewers and Editors.

Although Genome Medicine will not make general interest level an absolute criterion for publication, it aims to provide its readership with the highest quality research and information in genomic and post-genomic medicine, and will therefore focus on articles of general and outstanding interest.

All submitted research papers are subject to immediate rapid screening by the editors, in consultation with the Editorial Board if appropriate, to ensure they fall within the scope of the journal. Contributors who are in doubt about the suitability of their paper are welcome to send a presubmission enquiry. The editors will provide an initial response to all presubmission enquiries and submitted articles within five working days.

Manuscripts will be reviewed by internationally recognized experts in the fields of genomic and post-genomic medicine selected in part from our Editorial Board. Genome Medicine operates an anonymous peer review process. Reviews will be rapid and the suitability of a paper for publication will be assessed solely on criteria of scientific excellence. The editors will make every effort to give authors a decision following peer review within four weeks of an article's submission. Articles are published electronically as promptly as possible after they are accepted, and within one month of acceptance.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Genome Medicine, a personalized section of the site.

Copyediting and proofs

All articles published in Genome Medicine are copyedited before publication of the final version.

Research, Databases, Methods and Software articles published in Genome Medicine are published immediately on acceptance in the form of a provisional PDF. Copyedited and fully formatted PDF and full-text (HTML) versions are made available shortly after that.

Edited versions will be sent by email and corrections should be returned within two working days. Please provide a typed list of corrections clearly indicating where the corrections should be made and please send this list by email.

The editing of Research, Databases, Methods and Software articles is designed only to correct such things as misused words, spelling errors, missing references or incomplete citation information.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Genome Medicine will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Genome Medicine should adhere to BioMed Central's editorial policies.

Citing articles in Genome Medicine

Articles in Genome Medicine should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Genome Med [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Genome Med 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Genome Medicine?

High visibility

Genome Medicine's open access policy allows maximum visibility of research articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Genome Medicine offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Genome Medicine, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Genome Medicine gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Genome Medicine are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Genome Medicine's pages and on the BioMed Central homepage.

In addition, articles published in Genome Medicine may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Genome Medicine. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of research articles published in Genome Medicine retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.